Brain Scientific Financials
| BRSF Stock | USD 0.75 0.00 0.00% |
Brain |
Understanding current and past Brain Scientific Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Brain Scientific's financial statements are interrelated, with each one affecting the others. For example, an increase in Brain Scientific's assets may result in an increase in income on the income statement.
Brain Scientific Stock Summary
Brain Scientific competes with BICO Group, Aurora Spine, Tenon Medical, Ainos, and Cellink AB. Brain Scientific Inc., a medtech company, provides neurology-focused medical devices and electric motors in the United States. Brain Scientific Inc. was founded in 2013 and is headquartered in Sarasota, Florida. Brain Scientific operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 28 people.| Instrument | USA Pink Sheet View All |
| Exchange | PINK Exchange |
| Business Address | 6700 Professional Parkway, |
| Sector | Healthcare |
| Industry | Medical Devices |
| Benchmark | Dow Jones Industrial |
| Website | www.brainscientific.com |
| Phone | 917 388 1578 |
| Currency | USD - US Dollar |
Brain Scientific Key Financial Ratios
There are many critical financial ratios that Brain Scientific's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Brain Scientific reports annually and quarterly.| Return On Equity | -45.97 | |||
| Return On Asset | -1.17 | |||
| Number Of Employees | 28 | |||
| Beta | -0.88 | |||
| Z Score | 18.6 |
Brain Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Brain Scientific's current stock value. Our valuation model uses many indicators to compare Brain Scientific value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Brain Scientific competition to find correlations between indicators driving Brain Scientific's intrinsic value. More Info.Brain Scientific is rated second in return on equity category among its peers. It is rated third in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Brain Scientific's earnings, one of the primary drivers of an investment's value.Brain Scientific Systematic Risk
Brain Scientific's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Brain Scientific volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Brain Scientific correlated with the market. If Beta is less than 0 Brain Scientific generally moves in the opposite direction as compared to the market. If Brain Scientific Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Brain Scientific is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Brain Scientific is generally in the same direction as the market. If Beta > 1 Brain Scientific moves generally in the same direction as, but more than the movement of the benchmark.
Complementary Tools for Brain Pink Sheet analysis
When running Brain Scientific's price analysis, check to measure Brain Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Brain Scientific is operating at the current time. Most of Brain Scientific's value examination focuses on studying past and present price action to predict the probability of Brain Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Brain Scientific's price. Additionally, you may evaluate how the addition of Brain Scientific to your portfolios can decrease your overall portfolio volatility.
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |